Skip to main content
. 2013 Dec 18;3(12):e003898. doi: 10.1136/bmjopen-2013-003898

TableĀ 2.

Adherence of studies to modified CONSORT-NPT checklist

CONSORT number Point Overall adherence, n (%) Medical adherence, n (%) Surgical adherence, n (%)
1a Title and abstract 46 (85) 17 (77) 29 (91)
1b 7 (13)* 7 (32) 0
2a Background and objectives 54 (100) 22 (100) 32 (100)
2b 54 (100) 22 (100) 32 (100)
3a Trial design 22 (41) 14 (64) 8 (25)
3b 54 (100) 22 (100) 32 (100)
4a Participants 54 (100) 22 (100) 32 (100)
4b 13 (24)* 7 (32) 6 (19)
5 Interventions 48 (89) 19 (86) 29 (91)
5a 39 (72) 20 (91) 19 (59)
5b 50 (93) 20 (91) 30 (94)
5c 7 (13)* 6 (27) 1 (3)
6a Outcomes 48 (89) 22 (100) 26 (81)
6b 54 (100) 22 (100) 32 (100)
7a Sample size 3 (6)* 2 (9) 1 (3)
7b 52 (96) 22 (100) 30 (94)
8a Randomisation sequence generation 30 (56) 12 (55) 18 (56)
8b 9 (17)* 2 (9) 7 (22)
9 Allocation concealment mechanism 28 (52) 17 (77) 11 (34)
10 Randomisation implementation 18 (33) 13 (59) 5 (16)
11a Blinding 29 (54) 16 (73) 13 (41)
11b 30 (56) 16 (73) 14 (44)
12a Statistical methods 54 (100) 22 (100) 32 (100)
12b 2 (4)* 0 2 (6)
13a Participant flow 0* 0 0
13b 51 (94) 22 (100) 29 (91)
New Implementation of intervention 38 (70) 12 (55) 26 (81)
14a Recruitment 48 (89) 22 (100) 26 (81)
14b 51 (94) 22 (100) 29 (91)
15a Baseline data 52 (96) 22 (100) 30 (94)
15b 0* 0 0
16 Numbers analysed 52 (96) 22 (100) 30 (94)
17a Outcomes and estimation 21 (39) 18 (82) 3 (9)
17b 15 (28)* 14 (64) 1 (3)
18 Ancillary analyses 42 (78) 20 (91) 22 (29)
19 Harms 51 (94) 21 (95) 30 (94)
20 Limitations 35 (65) 19 (86) 16 (50)
21 Generalisability 24 (44) 14 (64) 10 (31)
22 Interpretation 51 (94) 22 (100) 29 (91)
23 Registration 49 (91) 22 (100) 27 (84)
24 Protocol 25 (46) 18 (82) 7 (22)
25 Funding 40 (74) 22 (100) 18 (56)

Headings in italics are covered within the CONSORT-NPT extension. Non-italics are exclusive to CONSORT 2010 statement. Further details available in online supplementary appendix S3.